mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.004 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.005 |
mRNA |
AP-24534 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.005 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |